Marc J. Schweiger

TNK–Tissue Plasminogen Activator Compared With Front-Loaded Alteplase in Acute Myocardial Infarction

Christopher P. Cannon, C. Michael Gibson, Carolyn H. McCabe et al. · Circulation · 1998 · 355 citations · Full text

A pilot trial of recombinant desulfatohirudin compared with heparin in conjunction with tissue-type plasminogen activator and aspirin for acute myocardial infarction: Results of the Thrombolysis in Myocardial Infarction (TIMI) 5 trial

Christopher P. Cannon, Carolyn H. McCabe, Timothy D. Henry et al. · Journal of the American College of Cardiology · 1994 · 258 citations

Thrombosis, Cardiovascular Disease, Medicine +10

Predictors of early morbidity and mortality after thrombolytic therapy of acute myocardial infarction. Analyses of patient subgroups in the Thrombolysis in Myocardial Infarction (TIMI) trial, phase II.

Hiltrud S. Mueller, Lawrence S. Cohen, Eugene Braunwald et al. · Circulation · 1992 · 233 citations

Nontuberculous mycobacteria in non‐HIV patients: epidemiology, treatment and response

Michael T. Henry, L. Inamdar, D. S. Ó’Ríordáin et al. · European Respiratory Journal · 2004 · 191 citations · Full text

Prognostic implications of elevated troponin in patients with suspected acute coronary syndrome but no critical epicardial coronary disease

Hisham Dokainish, Manu Pillai, Sabina A. Murphy et al. · Journal of the American College of Cardiology · 2004 · 127 citations

Percutaneous Coronary Intervention, Cardiovascular Disease, Elevated Troponin +7